If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Claudia Bighin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 77 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

Blondeaux, E., Lambertini, M., Michelotti, A., Conte, B., Benasso, M., Dellepiane, C., Bighin, C., Pastorino, S., Levaggi, A., Alonzo, A. D., Poggio, F., Buzzatti, G., Molinelli, C., Fregatti, P., Bertoglio, S., Boccardo, F. & Del Mastro, L., Jan 1 2020, (Accepted/In press) In : British Journal of Cancer.

Research output: Contribution to journalArticle

  • Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

    Lambertini, M., Poggio, F., Bruzzone, M., Conte, B., Bighin, C., de Azambuja, E., Giuliano, M., De Laurentiis, M., Cognetti, F., Fabi, A., Bisagni, G., Durando, A., Turletti, A., Urracci, Y., Garrone, O., Puglisi, F., Montemurro, F., Ceppi, M., Del Mastro, L. & investigators, GIM., Nov 13 2019, In : International Journal of Cancer. p. 10.1002/ijc.32789 10 p.

    Research output: Contribution to journalArticle

  • Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

    Lambertini, M., Poggio, F., Bruzzone, M., Conte, B., Bighin, C., de Azambuja, E., Giuliano, M., De Laurentiis, M., Cognetti, F., Fabi, A., Bisagni, G., Durando, A., Turletti, A., Urracci, Y., Garrone, O., Puglisi, F., Montemurro, F., Ceppi, M., Del Mastro, L. & investigators, O. B. O. T. GIM., Nov 13 2019, In : Int. J. Cancer.

    Research output: Contribution to journalArticle

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Apr 6 2019, In : The Lancet. 393, 10179, p. 1440-1452 13 p.

    Research output: Contribution to journalArticle

    Open Access